A marked rise in hospital admission rates for asthma among young people occurs during September and 'week 38' specifically. This is also known as the 'September Surge'. Take some time to prepare ahead of the surge with our clinical resources on #asthma🔎 ow.ly/K3Oo50T0Sgw

QRISK3 underestimates the risk of cardiovascular events in patients with COPD. thorax.bmj.com/content/79/8/… @mo_safavi

Breathless and heart broken in COPD, or why it’s important to be as interested in the blood pressure as the oxygen saturation. doi.org/10.1111/resp.14804

🌏Respirology Home oxygen guidelines: We do not know enough about LTOT- an expert view on the topic and linked to a recent TSANZ Clinical Practice Guideline in #Respirology #FreeAccess & #OpenAccess onlinelibrary.wiley.com/doi/… linked to onlinelibrary.wiley.com/doi/…

‘I can’t get air in’ We report the experience of living with #asthma and #vcd / #ilo ⁦@maj_ele⁩ ⁦@nessiewil⁩ ⁦@AnneAldrid87576⁩ ⁦@traitsCRE⁩ ⁦@HMRIAustralia⁩ ⁦@Uni_Newcastle⁩ jaci-inpractice.org/article/…

European Respiratory Review: Smoking in people who are otherwise eligible for home oxygen therapy poses a clinical challenge, where management should include a risk–benefit evaluation and medical, practical, legal and ethical considerations. bit.ly/3GDzXtm

ERJ: After initial therapy termination, resumption and continuation of CPAP therapy was associated with lower all-cause mortality risk than therapy resumption followed by a second termination. This highlights the value of offering a second CPAP trial. bit.ly/3N3RJcU

New paper! How effective is Pseudomonas eradication treatment in people with bronchiectasis and new isolation of PA? Answer: 40% will clear PA at 1 year. Much more effective (48% vs 27%) if you include an inhaled antibiotic Limitations: observational data only. We need RCTs

🔥🔥Applying the treatable traits approach in bronchiectasis-A scoping review of traits, measurements and treatments @ProfJDChalmers @EvaPolverino @AlibertiStefano @OSibila @FionaMosgrove @TobWel @Beika_Physio @MichalShteinbe1 @Shoemelia @nessmcd ➡️bit.ly/3tzDFBl

Protect our kids from #vaping. They are #cigarettes disguised in new wine skin.

Really helpful to have everything in one place- thanks to the Respiratory Futures team for all their work on this!

Phenotypes, Etiotypes, and Endotypes of Exacerbations of Chronic Obstructive Pulmonary Disease 🔗 bit.ly/49zYblo

Even more relevant today now that we will have a #biologic therapy available for patients with #COPD in the near future.

Tropical pulmonary eosinophilia should be considered in patients presenting with respiratory symptoms and hypereosinophilia, even in areas not endemic for filariasis. This awareness may prevent morbidity associated with its late or wrong diagnosis. bit.ly/3t8hHVc

Breathe: Beyond pulmonary function testing, functional imaging provides deeper insights into regional heterogeneity and mechanisms of respiratory diseases with the potential for early detection and better phenotyping bit.ly/48MZNrB

The prevalence of comorbidities in asthma is high. Untreated, these conditions can worsen asthma control, leading to reflexive escalation of therapy. Systematic assessment and management of these entities in severe asthma is of paramount importance. bit.ly/3LRGBPE

👀🆕 in @LancetRespirMed - our review entitled 'Unravelling the respiratory health path across the lifespan for those born too soon'. ▶️ thelancet.com/journals/lanre… Our key messages are... (🧵...)

“Blood eosinophil-directed prednisolone therapy at the time of an acute exacerbation of #COPD ... can be used to safely reduce systemic glucocorticoid use in clinical practice.” See results of the STARR2 trial from @SanjayResp @MonaBafadhel & colleagues: bit.ly/3FTL40Q

GOLD 2024 is coming soon! This year's update includes new guidance on smoking cessation, which has the greatest impact on the course of COPD, including improving daily symptoms and decreasing exacerbations. The new GOLD update outlines the best strategies to help your patients quit, including how to assess nicotine dependence. Studies show that even just three minutes of counseling can help improve smoking cessation rates! Register for this year's conference and be the first to hear the new 2024 GOLD updates. Day 1 of this year's event includes a clinical management session on how to help your patients STOP! Register: bit.ly/3OEFKCm

ERJ: Hospital admission for exacerbations of COPD fell only in non-T2-high patients during the COVID-19 pandemic and only in non-eosinophilic admissions. Phenotyping of AECOPD, including at time of exacerbation, is needed for personalised management. bit.ly/3ZiUtYx